- Filed
- Nov 16, 2020 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2020 · Nov 16, 2020 | 5.76M sh |
| Short Term Debt | Q3 2020 · Sep 30, 2020 | $1.03M |
| Short Term Debt | Q3 2020 · Dec 31, 2019 | $841K |
| Current Liabilities | Q3 2020 · Sep 30, 2020 | $4.68M |
| Current Liabilities | Q3 2020 · Dec 31, 2019 | $4.67M |
| Total Liabilities | Q3 2020 · Sep 30, 2020 | $5.73M |
| Total Liabilities | Q3 2020 · Dec 31, 2019 | $5.41M |
| Current Assets | Q3 2020 · Sep 30, 2020 | $119K |
| Current Assets | Q3 2020 · Dec 31, 2019 | $108K |
| Total Assets | Q3 2020 · Sep 30, 2020 | $130K |
| Total Assets | Q3 2020 · Dec 31, 2019 | $121K |
| Net Income | Q3 2020 · Jun 30, 2020 | −$184K |
| Net Income | Q3 2020 · Mar 31, 2020 | −$339K |
| Net Income | Q3 2020 · Sep 30, 2019 | −$273K |
| Net Income | Q3 2020 · Sep 30, 2019 | −$813K |
| Net Income | Q3 2020 · Jun 30, 2019 | −$249K |
| Net Income | Q3 2020 · Mar 31, 2019 | −$291K |
| Capex | Q3 2020 · Sep 30, 2019 | $9K |
| Operating Cash Flow | Q3 2020 · Sep 30, 2019 | −$289K |
| Cash And Equivalents | Q3 2020 · Sep 30, 2019 | $37K |
| Cash And Equivalents | Q3 2020 · Dec 31, 2018 | $335K |
| Stockholders Equity | Q3 2020 · Sep 30, 2019 | −$5.06M |
| Stockholders Equity | Q3 2020 · Jun 30, 2019 | −$5.04M |
| Stockholders Equity | Q3 2020 · Mar 31, 2019 | −$4.84M |
| Stockholders Equity | Q3 2020 · Dec 31, 2018 | −$4.61M |
| Sga Expense restated | Q3 2020 · Sep 30, 2019 | $194K |
| Sga Expense restated | Q3 2020 · Sep 30, 2019 | $588K |
| Rd Expense | Q3 2020 · Sep 30, 2019 | $179K |
| Rd Expense | Q3 2020 · Sep 30, 2019 | $531K |
| Operating Income restated | Q3 2020 · Sep 30, 2019 | −$198K |
| Operating Income restated | Q3 2020 · Sep 30, 2019 | −$608K |
| Revenue | Q3 2020 · Sep 30, 2019 | $213K |
| Revenue | Q3 2020 · Sep 30, 2019 | $638K |